NCT04387071 2026-04-17
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma
University of Southern California
Phase 1/2 Terminated
University of Southern California
Cancer Trials Ireland
Chinese University of Hong Kong